Sökning: (WFRF:(Battin M))
> (2020) >
A New Strategy Towa...
A New Strategy Toward B Cell-Based Cancer Vaccines by Active Immunization With Mimotopes of Immune Checkpoint Inhibitors
-
Tobias, J. (författare)
-
Battin, C. (författare)
-
Linhares, A. D. (författare)
-
visa fler...
-
- Lebens, Michael, 1956 (författare)
- Gothenburg University,Göteborgs universitet,Institutionen för biomedicin, avdelningen för mikrobiologi och immunologi,Institute of Biomedicine, Department of Microbiology and Immunology
-
Baier, K. (författare)
-
Ambroz, K. (författare)
-
Drinic, M. (författare)
-
Hogler, S. (författare)
-
Inic-Kanada, A. (författare)
-
Garner-Spitzer, E. (författare)
-
Preusser, M. (författare)
-
Kenner, L. (författare)
-
Kundi, M. (författare)
-
Zielinski, C. C. (författare)
-
Steinberger, P. (författare)
-
Wiedermann, U. (författare)
-
visa färre...
-
(creator_code:org_t)
- 2020-05-27
- 2020
- Engelska.
-
Ingår i: Frontiers in Immunology. - : Frontiers Media SA. - 1664-3224. ; 11
- Relaterad länk:
-
https://www.frontier...
-
visa fler...
-
https://gup.ub.gu.se...
-
https://doi.org/10.3...
-
visa färre...
Abstract
Ämnesord
Stäng
- Therapeutic monoclonal antibodies (mAbs), targeting tumor antigens, or immune checkpoints, have demonstrated a remarkable anti-tumor effect against various malignancies. However, high costs for mono- or combination therapies, associated with adverse effects or possible development of resistance in some patients, warrant further development and modification to gain more flexibility for this immunotherapy approach. An attractive alternative to passive immunization with therapeutic antibodies might be active immunization with mimotopes (B-cell peptides) representing the mAbs' binding epitopes, to activate the patient's own anti-tumor immune response following immunization. Here, we identified and examined the feasibility of inducing anti-tumor effectsin vivofollowing active immunization with a mimotope of the immune checkpoint programmed cell death 1 (PD1), alone or in combination with a Her-2/neu B-cell peptide vaccine. Overlapping peptides spanning the extracellular domains of human PD1 (hPD1) were used to identify hPD1-derived mimotopes, using the therapeutic mAb Nivolumab as a proof of concept. Additionally, forin vivoevaluation in a tumor mouse model, a mouse PD1 (mPD1)-derived mimotope was identified using an anti-mPD1 mAb with mPD1/mPDL-1 blocking capacity. The identified mimotopes were characterized byin vitroassays, including a reporter cell-based assay, and their anti-tumor effects were evaluated in a syngeneic tumor mouse model stably expressing human Her-2/neu. The identified PD1-derived mimotopes were shown to significantly block the mAbs' capacity in inhibiting the respective PD1/PD-L1 interactions. A significant reduction in tumor growthin vivowas observed following active immunization with the mPD1-derived mimotope, associated with a significant reduction in proliferation and increased apoptotic rates in the tumors. Particularly, combined vaccination with the mPD1-derived mimotope and a multiple B-cell epitope Her-2/neu vaccine potentiated the vaccine's anti-tumor effect. Our results suggest active immunization with mimotopes of immune checkpoint inhibitors either as monotherapy or as combination therapy with tumor-specific vaccines, as a new strategy for cancer treatment.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Medicinska och farmaceutiska grundvetenskaper -- Immunologi inom det medicinska området (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Basic Medicine -- Immunology in the medical area (hsv//eng)
Nyckelord
- mimotopes
- immune checkpoint inhibitors
- active immunization
- cancer
- therapy
- Her-2
- neu
- combination therapy
- breast-cancer
- blockade
- therapy
- immunotherapy
- Immunology
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Tobias, J.
-
Battin, C.
-
Linhares, A. D.
-
Lebens, Michael, ...
-
Baier, K.
-
Ambroz, K.
-
visa fler...
-
Drinic, M.
-
Hogler, S.
-
Inic-Kanada, A.
-
Garner-Spitzer, ...
-
Preusser, M.
-
Kenner, L.
-
Kundi, M.
-
Zielinski, C. C.
-
Steinberger, P.
-
Wiedermann, U.
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Medicinska och f ...
-
och Immunologi inom ...
- Artiklar i publikationen
-
Frontiers in Imm ...
- Av lärosätet
-
Göteborgs universitet